AstraZeneca, the drugmaker that developed one of the first Covid-19 vaccines, has asked the Food and Drug Administration to authorize the emergency use of a first-of-a-kind antibody treatment to prevent the disease.
The Anglo-Swedish company said Tuesday that the treatment, known as AZD7442, would be the first long-acting antibody combination to receive an emergency authorization for COVID-19 prevention. If authorized, the drug would likely be limited to people with compromised immune systems who don't get sufficient protection from vaccination.
"First and foremost we want to protect those vulnerable populations that haven’t been adequately protected by the vaccine," said Menelas Pangaloa, AstraZeneca's head of research and development.
Written by
DanBro1
To view profiles and participate in discussions please or .
I think it would be a great idea! It would be a very helpful tool in this pandemic. Unfortunately, the American government is still asleep at the wheel. If it gets approved, it will likely take a long time to get approval. It will be tied up in government procurement and bureaucrats deciding as to how best distribute these things.
I’m not trying to be “debbie-downer” but our country seems to be turning a blind eye to Covid when compared to earlier times. We cant even get home Covid tests on the market and plentiful.
So as “medical authorities” continue to argue the validity of booster shots for about the 6th week in a row, AZD7442 will get stuck in a big puddle of mud?
I wouldn’t be negative like this if it weren’t true. Covid needs to be #1 on a national agenda! We have the tools to stop Covid in its tracks - but we can’t seem to get the momentum to work on it.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.